Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory

Indian Journal of Medical Research

Volumn 142, Issue NOVEMBER, 2015, Pages 568-574

  Dusthackeer, Azger ^a   Sekar, Gomathi ^a   Chidambaram, Shambhavi ^b   Kumar, Vanaja ^c   Mehta, Pranav ^d   Swaminathan, Soumya ^a,e  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b WOMEN S CHRISTIAN COLLEGE   (India)

^c METROPOLITAN HOSPITAL CENTER   (United States)

^d SATHYABAMA UNIVERSITY   (India)

^e INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Drug resistance; Extrapulmonary tuberculosis; MDR TB; Mycobacterium tuberculosis; XDR TB

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; LABORATORY; REFERENCE VALUE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; LABORATORIES; REFERENCE VALUES; TUBERCULOSIS;

EID: 84949549517     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: 10.4103/0971-5916.171284     Document Type: Article

References (28)

1. World Health Organization. Global Tuberculosis Report 2014. [WHO/HTM/TB/2014.08] 2014. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng. pdf, accessed on July 22, 2014.
2. RNTCP. Response to challenges of drug resistant TB in India January 2012 (Update). Available from: http://www.tbcindia.nic.in/pdfs/RNTCP%20Response%20DR%20TB%20in%20 India%20-%20Jan%202012%20update.pdf, accessed on July 22, 2014.
3. Wares F, Balasubramanian R, Mohan A, Sharma SK. Extrapulmonary tuberculosis: management and control. In: Agarwal SP, Chauhan LS, editors. Tuberculosis control in India. New Delhi: Directorate General of Health Services. Ministry of Health and Family Welfare; 2005. p. 95-114.
4. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004; 120 : 316-53.
5. th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO; 2010.
6. Maurya AK, Kant S, Nag VL, Kushwaha RA, Dhole TN. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. J Postgrad Med 2012; 58 : 185-9.
7. Central TB Division. TB India 2014, Revised National TB Control Programme, Annual Status Report. 2014. Available from: http://www.tbcindia.nic.in/pdfs/tb%20India%202014.pdf, accessed on October 22, 2015.
8. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009; 13 : 1154-60.
9. Central TB Division. National Scale-up Plan for the Programmatic Management of Drug-Resistant Tuberculosis (PMDT). 2011-2012. Available from: http://tbcindia.nic.in/pdfs/National%20PMDT%20Scale-up%20Plan%20-%20 India%20-%202011-12.pdf, accessed on July 22, 2014.
10. World Health Organization (WHO). Laboratory services in tuberculosis control. WHO/TB/98.258. Geneva, Switzerland: WHO; 1998.
11. Mitchison DA, Aber VR. Culture of specimens other than sputum for mycobacteria. J Clin Pathol 1974; 27 : 883-7.
12. National Institute for Research in Tuberculosis, Department of Bacteriology; 2010. Available from: http://ijmr.org.in/contributors.asp, accessed on July 22, 2014.
13. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
14. Sulochana S, Rahman F, Paramasivan CN. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. J Chemother 2005; 17 : 169-73.
15. Ramachandran P, Duraipandian M, Nagarajan M, Prabhakar R, Ramakrishnan CV, Tripathy SP. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986; 67 : 17-29.
16. Jawahar MS, Sivasubramanian S, Vijayan VK, Ramakrishnan CV, Paramasivan CN, Selvakumar V, et al. Short course chemotherapy for tuberculous lymphadenitis in children. BMJ 1990; 301 : 359-62.
17. Balasubramanian R, Nagarajan M, Balambal R, Tripathy SP, Sundararaman R, Venkatesan P, et al. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report. Int J Tuberc Lung Dis 1997; 1 : 44-51.
18. Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, et al. Treatment of lymph node tuberculosis - a randomized clinical trial of two 6-month regimens. Trop Med Int Health 2005; 10 : 1090-8.
19. Umapathy KC, Begum R, Ravichandran G, Rahman F, Paramasivan CN, Ramanathan VD. Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Trop Med Int Health 2006; 11 : 1521-8.
20. Swaminathan S, Datta M, Radhamani MP, Mathew S, Reetha AM, Rajajee S, et al. A profile of bacteriologically confirmed pulmonary tuberculosis in children. Indian Pediatr 2008; 45 : 743-7.
21. Vadwai V, Shetty A, Supply P, Rodrigues C. Evaluation of 24-locus MIRU-VNTR in extrapulmonary specimens: study from a tertiary centre in Mumbai. Tuberculosis (Edinb) 2012; 92 : 264-72.
22. Gurung R, Bhattacharya SK, Pradhan B, Gurung S, Singh YI. Phenotypic characterisation and drug sensitivity testing of mycobacteria isolated from extra-pulmonary tuberculosis. Kathmandu Univ Med J (KUMJ) 2010; 8 : 57-61.
23. Sachdeva R, Gadre DV, Talwar V. Characterisation & drug susceptibility patterns of extrapulmonary mycobacterial isolates. Indian J Med Res 2002; 115 : 102-7.
24. Paramasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, et al. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis 2010; 14 : 243-6.
25. Pawar UM, Kundnani V, Agashe V, Nene A. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients. Spine 2009; 34 : E806-10.
26. Schaaf HS, Victor TC, Venter A, Brittle W, Jordaan AM, Hesseling AC, et al. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis 2009; 13 : 1355-9.
27. Central TB Division. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. 2012. Available from: http://www.tbcindia.nic.in/pdfs/Guidelines%20for%20 PMDT%20in%20India%20-%20May%202012.pdf, accessed on July 22, 2014.
28. Sinha SK, Chatterjee M, Bhattacharya S, Pathak SK, Mitra RB, Karak K, et al. Diagnostic evaluation of extrapulmonary tuberculosis by fine needle aspiraton (FNA) supplemented with AFB smear and culture. J Indian Med Assoc 2003; 101 : 588, 590-1.